Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia

B. Yee; J. Chapman; R. Grunstein; C. Argent; A. D'Rozario; C. Hopkinson; J. Ramos; I. Landry; S. Yagoda; B. Rege

doi:10.1016/j.sleep.2023.11.621

Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia

B. Yee, J. Chapman, R. Grunstein, C. Argent, A. D'Rozario, C. Hopkinson, J. Ramos, I. Landry, S. Yagoda, B. Rege

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	224-225
Number of pages	2
Journal	Sleep Medicine
Volume	115
Issue number	S1
DOIs	https://doi.org/10.1016/j.sleep.2023.11.621
Publication status	Published - Feb 2024
Externally published	Yes
Event	17th World Sleep Congress, World Sleep 2023 - Rio de Janeiro, Brazil Duration: 20 Oct 2023 → 25 Oct 2023

Access to Document

10.1016/j.sleep.2023.11.621

Cite this

Yee, B., Chapman, J., Grunstein, R., Argent, C., D'Rozario, A., Hopkinson, C., Ramos, J., Landry, I., Yagoda, S., & Rege, B. (2024). Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia. Sleep Medicine, 115(S1), 224-225. https://doi.org/10.1016/j.sleep.2023.11.621

@article{e7f0d154a8564d72b916c43ef33992b4,

title = "Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia",

author = "B. Yee and J. Chapman and R. Grunstein and C. Argent and A. D'Rozario and C. Hopkinson and J. Ramos and I. Landry and S. Yagoda and B. Rege",

year = "2024",

month = feb,

doi = "10.1016/j.sleep.2023.11.621",

language = "English",

volume = "115",

pages = "224--225",

journal = "Sleep Medicine",

issn = "1389-9457",

publisher = "Elsevier",

number = "S1",

note = "17th World Sleep Congress, World Sleep 2023 ; Conference date: 20-10-2023 Through 25-10-2023",

}

Yee, B, Chapman, J, Grunstein, R, Argent, C, D'Rozario, A, Hopkinson, C, Ramos, J, Landry, I, Yagoda, S & Rege, B 2024, 'Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia', Sleep Medicine, vol. 115, no. S1, pp. 224-225. https://doi.org/10.1016/j.sleep.2023.11.621

TY - JOUR

T1 - Preliminary results from a phase 1 study of ALKS 2680, an orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia

AU - Yee, B.

AU - Chapman, J.

AU - Grunstein, R.

AU - Argent, C.

AU - D'Rozario, A.

AU - Hopkinson, C.

AU - Ramos, J.

AU - Landry, I.

AU - Yagoda, S.

AU - Rege, B.

PY - 2024/2

Y1 - 2024/2

U2 - 10.1016/j.sleep.2023.11.621

DO - 10.1016/j.sleep.2023.11.621

M3 - Meeting abstract

SN - 1389-9457

VL - 115

SP - 224

EP - 225

JO - Sleep Medicine

JF - Sleep Medicine

IS - S1

T2 - 17th World Sleep Congress, World Sleep 2023

Y2 - 20 October 2023 through 25 October 2023

ER -